Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | FDPS | P14324 | 2/20 | 0.46 |
| ▸ | PTPRA | P18433 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LIN28A | Q9H9Z2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11554275 | 0.98 | LMNA (0.53) | TDP1LMNASMN1; SMN2L3MBTL1KMT2A | |
| SCHEMBL8940055 | 0.91 | LMNA (0.47) | TDP1LMNASMN1; SMN2L3MBTL1KMT2A | |
| SCHEMBL9600152 | 0.83 | KMT2A (0.50) | TDP1LMNASMN1; SMN2L3MBTL1KMT2A | |
| Phenylmethanesulfonic Acid SCHEMBL6115229 | 0.82 | TDP1 (0.50) | TDP1LMNASMN1; SMN2L3MBTL1KMT2A | |
| SCHEMBL5516006 | 0.81 | KMT2A (0.49) | TDP1LMNASMN1; SMN2L3MBTL1KMT2A | |
| SCHEMBL497367 | 0.80 | LMNA (0.60) | TDP1LMNASMN1; SMN2L3MBTL1KMT2A | |
| SCHEMBL5432527 | 0.80 | TDP1 (0.47) | TDP1LMNASMN1; SMN2L3MBTL1KMT2A | |
| Phenylmethanesulfonic Acid SCHEMBL7752154 | 0.79 | TDP1 (0.44) | TDP1LMNASMN1; SMN2L3MBTL1KMT2A | |
| SCHEMBL1272069 | 0.79 | KMT2A (0.47) | TDP1LMNASMN1; SMN2L3MBTL1KMT2A | |
| SCHEMBL1272072 | 0.79 | LMNA (0.54) | TDP1LMNASMN1; SMN2L3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112079793-B | Refining process and equipment for mass production of bentazone | 江苏剑牌农化股份有限公司 | 2023-08-01 | — | — | CN | claimed |
| US-20130189368-A1 | NANOPARTICULATE COMPOSITION CONTAINING ANTIBIOTICS FOR INTRAMAMMARY ADMINISTRATION IN ANIMALS | UNIVERSIDADE FEDERAL DE OURO PRETO (BR) | 2013-07-25 | — | — | US | claimed |
| CN-103118670-A | Nanoparticle compositions containing antibiotics for intramammary administration in animals | UNIV FED OURO PRETO | 2013-05-22 | — | — | CN | claimed |
| EP-2578577-A1 | Sulfonyl esters of tetrahydrocannabinol and derivatives thereof | Albany Molecular Research, Inc. (US) | 2013-04-10 | — | — | EP | claimed |
| EP-2578209-A1 | NANOPARTICULATE COMPOSITION CONTAINING ANTIBIOTICS FOR INTRAMAMMARY ADMINISTRATION IN ANIMALS | Universidade Federal De Ouro Preto (BR) | 2013-04-10 | — | — | EP | claimed |
| US-7674922-B2 | Process for production of delta-9-tetrahydrocannabinol | ALBANY MOLECULAR RESEARCH, INC. (US) | 2010-03-09 | — | — | US | claimed |
| EP-1928853-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR Technology, Inc. (US) | 2008-06-11 | — | — | EP | claimed |
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | AMR TECHNOLOGY, INC. (US) | 2007-04-26 | — | — | US | claimed |
| WO-2007041167-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR TECHNOLOGY, INC. (US) | 2007-04-12 | — | — | WO | claimed |
| EP-1474435-B1 | PROCESS FOR THE PREPARATION OF 6-ALPHA FLUORINATED PREGNANES | SICOR INC (US) | 2006-02-22 | — | — | EP | claimed |
| EP-0934339-A1 | IgG IMMUNOGLOBULINS AND F(ab') 2? FRAGMENTS THEREOF, SPECIFIC FOR DRUGS AND METABOLITES THEREOF, AND THEIR USE FOR DETOXIFICATION PURPOSES | DOX-AL ITALIA S.p.A. (IT) | 1999-08-11 | — | — | EP | claimed |
| WO-1997049732-A1 | IgG IMMUNOGLOBULINS AND F(ab')2 FRAGMENTS THEREOF, SPECIFIC FOR DRUGS AND METABOLITES THEREOF, AND THEIR USE FOR DETOXIFICATION PURPOSES | DOX-AL ITALIA S.P.A. (IT) | 1997-12-31 | — | — | WO | claimed |
| EP-0146738-B1 | ANTIMICROBIAL ANIMAL FEED ADDITIVE COMPOSITIONS | AMERICAN CYANAMID COMPANY (US) | 1990-12-19 | — | — | EP | claimed |
| EP-0146738-A2 | Antimicrobial animal feed additive compositions | AMERICAN CYANAMID COMPANY (US) | 1985-07-03 | — | — | EP | claimed |
| CN-115175950-B | Curable compositions of benzoxazine and phthalonitrile resins | 亨斯迈先进材料美国有限责任公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-112079793-B | Refining process and equipment for mass production of bentazone | 江苏剑牌农化股份有限公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-112079793-B | Refining process and equipment for mass production of bentazone | 江苏剑牌农化股份有限公司 | 2023-08-01 | — | — | CN | disclosed |
| US-4865925-A | ANODE, CATHODE COMPARTMENT; SEPARATOR MEMBRANE | HUGHES AIRCRAFT COMPANY (US) | 1989-09-12 | — | — | US | disclosed |
| CN-86100895-A | GOLD ELECTROPLATING BATH | — | 1986-07-16 | — | — | CN | disclosed |
| US-4415574-A | BACTERICIDES; MEDICINES; POTENTIATION OF SULFA DRUGS | S. A. PANMEDICA (FR) | 1983-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | CNR2, CNR1, HRH4 | TDP1 4660/4885LMNA 3504/4885SMN1; SMN2 4771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.